Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 127

1.

Liver Illness and Psychiatric Patients.

Carrier P, Debette-Gratien M, Girard M, Jacques J, Nubukpo P, Loustaud-Ratti V.

Hepat Mon. 2016 Dec 3;16(12):e41564. doi: 10.5812/hepatmon.41564. Review.

2.

Gastric peroral endoscopic pyloromyotomy as a salvage therapy for refractory gastroparesis: a case series of different subtypes.

Jacques J, Legros R, Monteil J, Loustaud-Ratti V, Sautereau D.

Neurogastroenterol Motil. 2017 Jan;29(1). doi: 10.1111/nmo.12932. No abstract available.

PMID:
28028897
3.

Anti-hepatitis C virus drugs and kidney.

Carrier P, Essig M, Debette-Gratien M, Sautereau D, Rousseau A, Marquet P, Jacques J, Loustaud-Ratti V.

World J Hepatol. 2016 Nov 18;8(32):1343-1353. Review.

4.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

Ducancelle A, Pivert A, Bertrais S, Boursier J, Balan V, Veillon P, le Guillou-Guillemette H, Thibault V, Castelain S, Roquebert B, Coste-Burel M, Mackiewicz V, Schvoerer E, Larrat S, Maylin S, Alain S, Loustaud-Ratti V, Gordien E, Gozlan J, Brodard V, Chevaliez S, Calès P, Lunel-Fabiani F.

J Gastroenterol Hepatol. 2016 Oct;31(10):1750-1756. doi: 10.1111/jgh.13338.

PMID:
26992056
5.

Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.

Lainé F, Ruivard M, Loustaud-Ratti V, Bonnet F, Calès P, Bardou-Jacquet E, Sacher-Huvelin S, Causse X, Beusnel C, Renault A, Bellissant E, Deugnier Y; Study Group..

Hepatology. 2017 Feb;65(2):465-474. doi: 10.1002/hep.28856.

PMID:
27685251
6.

Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients.

Debette-Gratien M, Woillard JB, Picard N, Sebagh M, Loustaud-Ratti V, Sautereau D, Samuel D, Marquet P.

Transplantation. 2016 Oct;100(10):2129-2137.

PMID:
27653228
7.

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.

Pol S, Bourliere M, Lucier S, Hezode C, Dorival C, Larrey D, Bronowicki JP, Ledinghen VD, Zoulim F, Tran A, Metivier S, Zarski JP, Samuel D, Guyader D, Marcellin P, Minello A, Alric L, Thabut D, Chazouilleres O, Riachi G, Bourcier V, Mathurin P, Loustaud-Ratti V, D'Alteroche L, Fouchard-Hubert I, Habersetzer F, Causse X, Geist C, Rosa I, Gournay J, Saillard E, Billaud E, Petrov-Sanchez V, Diallo A, Fontaine H, Carrat F; ANRS/AFEF HEPATHER study group..

J Hepatol. 2017 Jan;66(1):39-47. doi: 10.1016/j.jhep.2016.08.021.

PMID:
27622858
8.

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, Visentini M, Torres HA, Loustaud-Ratti V, Peveling-Oberhag J, Fabris P, Rossotti R, Zaja F, Rigacci L, Rattotti S, Bruno R, Merli M, Dorival C, Alric L, Jaccard A, Pol S, Carrat F, Ferretti VV, Visco C, Hermine O.

Blood. 2016 Nov 24;128(21):2527-2532.

PMID:
27605512
9.

A local structured training program with live pigs allows performing ESD along the gastrointestinal tract with results close to those of Japanese experts.

Jacques J, Legros R, Charissoux A, Mesturoux L, Couquet CY, Carrier P, Tabouret T, Valgueblasse V, Debette-Gratien M, Le-Sidaner A, Loustaud-Ratti V, Sautereau D.

Dig Liver Dis. 2016 Dec;48(12):1457-1462. doi: 10.1016/j.dld.2016.08.111.

PMID:
27590842
10.

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.

Loustaud-Ratti V, Maynard M, Thevenon S, Pradat P, Rousseau A, Alain S, Deny P, Gagnieu MC, Tran A, Dao T, Silvain C, Lunel-Fabiani F, Picard N, Zublena I, Marquet P, Trepo C; RIBAJUSTE Group..

Ther Drug Monit. 2016 Dec;38(6):684-692.

PMID:
27559840
11.

Peroral endoscopic pyloromyotomy accelerates gastric emptying in healthy pigs: proof of concept.

Geyl S, Legros R, Charissou A, Mesturoux L, Couquet CY, Carrier P, Brayette A, El-Ouafi Z, Loustaud-Ratti V, Sautereau D, Monteil J, Jacques J.

Endosc Int Open. 2016 Jul;4(7):E796-9. doi: 10.1055/s-0042-108192.

12.

Rare HFE variants are the most frequent cause of hemochromatosis in non-c282y homozygous patients with hemochromatosis.

Hamdi-Rozé H, Beaumont-Epinette MP, Ben Ali Z, Le Lan C, Loustaud-Ratti V, Causse X, Loreal O, Deugnier Y, Brissot P, Jouanolle AM, Bardou-Jacquet E.

Am J Hematol. 2016 Dec;91(12):1202-1205. doi: 10.1002/ajh.24535.

PMID:
27518069
13.

Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.

Abergel A, Metivier S, Samuel D, Jiang D, Kersey K, Pang PS, Svarovskaia E, Knox SJ, Loustaud-Ratti V, Asselah T.

Hepatology. 2016 Oct;64(4):1049-56. doi: 10.1002/hep.28706.

PMID:
27351341
14.

Endoscopic mucosectomy of the normal mucosa facilitates exposure of the submucosal layer at the commencement of colorectal endoscopic submucosal dissection.

Jacques J, Legros R, Carrier P, Geyl S, Loustaud-Ratti V, Sautereau D, Pioche M.

Endoscopy. 2016;48 Suppl 1:E213-4. doi: 10.1055/s-0042-109054. No abstract available.

PMID:
27310893
15.

Ribavirin: Past, present and future.

Loustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P.

World J Hepatol. 2016 Jan 18;8(2):123-30. doi: 10.4254/wjh.v8.i2.123. Review.

16.

Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study.

Abergel A, Asselah T, Metivier S, Kersey K, Jiang D, Mo H, Pang PS, Samuel D, Loustaud-Ratti V.

Lancet Infect Dis. 2016 Apr;16(4):459-64. doi: 10.1016/S1473-3099(15)00529-0.

PMID:
26803446
17.

Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?

Veillon P, Fouchard-Hubert I, Larrey D, Dao MT, D'alteroche L, Boyer-Darrigand N, Picard N, Le Guillou-Guillemette H, Saulnier P, Ducancelle A, Loustaud-Ratti V, Lunel-Fabiani F.

J Interferon Cytokine Res. 2016 Mar;36(3):204-14. doi: 10.1089/jir.2015.0131.

PMID:
26700738
18.

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.

About F, Oudot-Mellakh T, Niay J, Rabiéga P, Pedergnana V, Duffy D, Sultanik P, Cagnot C, Carrat F, Marcellin P, Zoulim F, Larrey D, Hézode C, Fontaine H, Bronowicki JP, Pol S, Albert ML, Theodorou I, Cobat A, Abel L; ANRS CO20-CUPIC study group..

PLoS One. 2015 Dec 15;10(12):e0145105. doi: 10.1371/journal.pone.0145105.

19.

[Hepatic encephalopathy].

Jacques J, Carrier P, Debette-Gratien M, Sobesky R, Loustaud-Ratti V.

Presse Med. 2016 Jan;45(1):46-59. doi: 10.1016/j.lpm.2015.02.021. French.

PMID:
26597584
20.

Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.

Daher R, Kannengiesser C, Houamel D, Lefebvre T, Bardou-Jacquet E, Ducrot N, de Kerguenec C, Jouanolle AM, Robreau AM, Oudin C, Le Gac G, Moulouel B, Loustaud-Ratti V, Bedossa P, Valla D, Gouya L, Beaumont C, Brissot P, Puy H, Karim Z, Tchernitchko D.

Gastroenterology. 2016 Mar;150(3):672-683.e4. doi: 10.1053/j.gastro.2015.10.049.

PMID:
26582087

Supplemental Content

Loading ...
Support Center